EUVIMEDEUVIMED entdecken
Crossref

Plasma glial fibrillary acidic protein and neurological diseases: A bidirectional Mendelian randomization study

Deming Jiang iD, Ailing Yue, Haitian Nan, Jiahui Hou, Min Chu iD, Yihao Wang, Liyong Wu iD

Journal of Alzheimer’s Disease · 2025-09 · 107 (2) · 806-818

DOI: 10.1177/13872877251362496 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, 2025-09. Verfasst von Deming Jiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Glial Fibrillary Acidic Protein, Nervous System Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Increased glial fibrillary acidic protein (GFAP) in blood, a biomarker of reactive astrogliosis and astrocytic injury, was observed in a variety of neurological disorders. However, the causal relationship between plasma GFAP and neurological disorders remains unclear.

Objective

We aim to investigate causal association between plasma GFAP levels and neurological disorders using bidirectional Mendelian randomization (MR).

Methods

The genome-wide association studies for neurological disorders, including neurodegenerative diseases, neuroimmune disorders, cerebrovascular diseases, and epilepsy, were collected. Genetic variables associated with plasma GFAP levels were obtained from the UK Biobank Pharma Proteomics Project. Inverse variance weighted or Wald ratio method was used as the main analysis to assess the causal association.

Results

Genetically predicted higher plasma GFAP levels were found to be associated with an increased risk of encephalitis (odds ratio [OR] = 2.52; 95% confidence interval [CI] = 1.67–3.47; p = 1.22 × 10 –5 ). Furthermore, we found that Alzheimer's disease (β = 0.05; standard error [SE] = 0.01; p = 6.63 × 10 –8 ), frontotemporal dementia (β = 0.12; SE = 0.01; p = 5.10 × 10 –16 ), and dementia with Lewy bodies (β = 0.08; SE = 0.02; p = 5.45 × 10 –5 ) were causally linked to an increase in plasma GFAP levels. Even after controlling for the influence of aging, these associations remained significant.

Conclusions

Our study found that higher plasma GFAP levels may increase the risk of encephalitis, while neurodegenerative dementia may enhance the plasma GFAP levels, supporting the clinical utility of blood GFAP as a reliable biomarker in neurological diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glial Fibrillary Acidic ProteinNervous System DiseasesHumansMendelian Randomization AnalysisGenome-Wide Association StudyBiomarkersMaleFemaleAlzheimer Disease

Stichwörter der Autor:innen

Alzheimer's diseaseMendelian randomizationagingencephalitisfrontotemporal dementiaplasma GFAP

Substanzen

Glial Fibrillary Acidic ProteinGFAP protein, humanBiomarkers

Autor:innen und Institutionen

  • Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.

ORCID-Profile: Deming Jiang, Min Chu, Liyong Wu

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Jiang, D., Yue, A., Nan, H., Hou, J., Chu, M., Wang, Y., & Wu, L. (2025). Plasma glial fibrillary acidic protein and neurological diseases: A bidirectional Mendelian randomization study. Journal of Alzheimer’s Disease, 107(2), 806-818. https://doi.org/10.1177/13872877251362496

Vancouver

Jiang D, Yue A, Nan H, Hou J, Chu M, Wang Y, et al. Plasma glial fibrillary acidic protein and neurological diseases: A bidirectional Mendelian randomization study. Journal of Alzheimer’s Disease. 2025;107(2):806-818. doi:10.1177/13872877251362496

BibTeX
@article{Jiang2025,
  author = {Jiang, Deming and Yue, Ailing and Nan, Haitian and Hou, Jiahui and Chu, Min and Wang, Yihao and Wu, Liyong},
  title = {Plasma glial fibrillary acidic protein and neurological diseases: A bidirectional Mendelian randomization study},
  journal = {Journal of Alzheimer’s Disease},
  year = {2025},
  volume = {107},
  number = {2},
  pages = {806--818},
  doi = {10.1177/13872877251362496}
}
Kostenlos starten →